CE3 Systematic Review and Indirect Comparison of PD-(L)1 Inhibitors in Combination with Platinum-Based Doublet Chemotherapy (PT-DC) for the First-Line Treatment of Non-Squamous, Non-Small-Cell Lung Cancer (nsqNSCLC)
Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.013
https://www.valueinhealthjournal.com/article/S1098-3015(21)00230-8/fulltext
Title :
CE3 Systematic Review and Indirect Comparison of PD-(L)1 Inhibitors in Combination with Platinum-Based Doublet Chemotherapy (PT-DC) for the First-Line Treatment of Non-Squamous, Non-Small-Cell Lung Cancer (nsqNSCLC)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)00230-8&doi=10.1016/j.jval.2021.04.013
First page :
Section Title :
Open access? :
No
Section Order :
10491